Atherosclerotic Renal Artery Stenosis

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Diagnostic Imaging

Background:

• Renal artery stenosis (RAS) diagnosis hinges on clinical suspicion and noninvasive imaging.
• Three key clinical syndromes include renin-dependent hypertension, essential hypertension, and ischemic nephropathy.
• Clinical indicators for RAS include abrupt hypertension, unexplained azotemia, ACE inhibitor-induced azotemia, and asymmetric renal size.

Purpose of the Study:

• To outline clinical syndromes associated with renal artery stenosis.
• To detail diagnostic indicators and therapeutic strategies for RAS.
• To identify optimal candidates for renal artery revascularization.

Main Methods:

• Clinical diagnosis based on patient history, symptoms, and laboratory findings.
• Noninvasive imaging modalities for confirmation.
• Review of therapeutic outcomes for different RAS etiologies and patient groups.

Main Results:

• Young women with fibromuscular dysplasia (FMD) often have renin-dependent hypertension, responding well to ACE inhibitors or angioplasty.
• Elderly patients with atherosclerotic renal artery stenosis (ARAS) typically have essential hypertension, managed primarily with medical therapy.
• Renal revascularization in ARAS is considered for refractory hypertension or end-organ injury, with stenting being the preferred method.

Conclusions:

• RAS management requires differentiating between FMD and ARAS, tailoring treatment to the underlying cause and patient profile.
• Renal revascularization offers benefits for specific ARAS patient subgroups, particularly those with end-organ damage.
• Early intervention for ischemic nephropathy is crucial, with optimal candidates for revascularization exhibiting specific clinical and imaging markers.